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CLINICAL RESEARCH ARTICLE
The influence of depression-PTSD comorbidity on health-related quality of
life in treatment-seeking veterans
Callista Forchuka, Anthony Nazarova,b,c, Renee Hunta,b, Brent Davisa,d, Kate St. Cyra,e and J. Don Richardsona,b,c,f
aThe MacDonald Franklin OSI Research Centre, Parkwood Institute, St. Joseph’s Health Care, London, Ontario, Canada; bDepartment of
Psychiatry, Western University, London, Ontario, Canada; cDepartment of Psychiatry and Behavioral Neurosciences, McMaster University,
Hamilton, Ontario, Canada; dComputer Science Department, Western University, London, Ontario, Canada; eDalla Lana School of Public
Health, University of Toronto, Toronto, Ontario, Canada; fOSI Clinic, Parkwood Institute, St. Joseph’s Health Care, London, Ontario,
Canada
ABSTRACT
Objective: Posttraumatic stress disorder (PTSD) and depression substantially impair health-
related quality of life (HRQOL) for many Canadian Armed Forces (CAF) veterans. Although
PTSD and depression are highly comorbid, little is known about whether the disorders may
interact in their association with HRQOL. We sought to investigate whether depressive
symptoms modify the relation between PTSD and HRQOL in treatment-seeking veterans.
Method: We accessed the clinical data of 545 CAF veterans aged 18 to 65 years who were
seeking treatment at a specialized clinic in London, Ontario. We used hierarchical linear
regression to assess the additive and multiplicative relations between depression and PTSD
symptoms on HRQOL, controlling for age and alcohol/substance abuse. Simple slopes were
examined to probe significant interactions.
Results: Probable PTSD and major depression were present in 77.4% and 85.3% of the
sample, respectively, and 73.0% of the sample presented with probable PTSD-depression
comorbidity. Depression symptoms significantly modified the relation between PTSD
symptoms and overall mental HRQOL (β = 0.12, p <0.001, ΔR2 = 0.014), and role
impairment due to emotional difficulties (β = 0.20, p <0.001, ΔR2 = 0.035). Simple
slope analyses revealed the impact of PTSD was greater among those with lower
depression symptoms and became weaker with greater depression symptom severity.
In adjusted models, only depression was significantly associated with all mental and
physical HRQOL domains; PTSD was not associated with physical HRQOL, role emotional
impairment, or vitality.
Conclusions: For those with severe comorbid depression, PTSD symptoms were no longer
associated with mental HRQOL, particularly in areas related to emotional functioning.
Findings suggest the importance of targeting depression in patients presenting with PTSD-
depression comorbidity.
La influencia de la comorbilidad depresión-TEPT en la calidad de
vida relacionada con la salud en los veteranos que buscan
tratamiento
Objetivo: El trastorno de estrés postraumático (TEPT) y la depresión afectan sustancialmente
la calidad de vida relacionada con la salud (CVRS) para muchos veteranos de las Fuerzas
Armadas de Canadá (CAF). Aunque TEPT y depresión son altamente comórbidos, poco se
sabe acerca de si los trastornos pueden interactuar en su asociación con la CVRS. Quisimos
investigar si los síntomas depresivos modifican la relación entre el TEPT y la CVRS en los
veteranos que buscan tratamiento.
Método: Accedimos a los datos clínicos de 545 veteranos de CAF de 18 a 65 años que
buscaban tratamiento en una clínica especializada en London, Ontario. Utilizamos
regresión lineal jerárquica para evaluar las relaciones aditivas y multiplicativas entre
depresión y síntomas de TEPT en la CVRS, controlando por edad y abuso de alcohol/
sustancias. Las pendientes simples se examinaron para investigar interacciones
significativas.
Resultados: TEPT probable y depresión mayor estaban presentes en el 77.4% y el 85.3% de
la muestra, respectivamente, y el 73.0% de la muestra presentaba comorbilidad probable
TEPT-depresión. Los síntomas de depresión modificaron significativamente la relación entre
los síntomas de TEPT y la CVRS mental general (β = 0.12, p <0.001, ΔR2 = 0.014), y el
deterioro de rol debido a dificultades emocionales (β = 0.20, p <0.001, ΔR2 = 0.035). Los
análisis de pendiente simple revelaron que el impacto del TEPT fue mayor entre aquellos
con síntomas de depresión más bajos y se debilitaron con una mayor gravedad de los
síntomas de depresión. En los modelos ajustados, solo la depresión se asoció
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significativamente con todos los dominios de CVRS mental y física; El TEPT no se asoció con
la CVRS física, deterioro emocional de rol o la vitalidad.
Conclusiones: Para aquellos con depresión comórbida severa, los síntomas de TEPT ya no se
asociaban con la CVRS mental, particularmente en áreas relacionadas con el funcionamiento
emocional. Los hallazgos sugieren la importancia de enfocarse en la depresión en pacientes
que presentan comorbilidad de TEPT-depresión.
抑郁-PTSD共病对寻求治疗的退伍军人健康相关生活质量的影响
目标: 创伤后应激障碍 (PTSD) 和抑郁症严重损害了许多加拿大武装部队 (CAF) 退伍军人的
健康相关生活质量 (HRQOL) 。尽管PTSD和抑郁症高度共发, 但对于这些疾病与HRQOL的关
联中是否可能存在交互作用知之甚少。我们试图考查寻求治疗的退伍军人中, 抑郁症状是
否会影响PTSD与HRQOL之间的关系。
方法: 我们获得了在安大略省伦敦市一家专科门诊接受治疗的545名18至65岁的CAF退伍军
人的临床数据。我们控制了年龄和酒精/药物滥用, 使用分层线性回归来评估抑郁与PTSD
症状之间加性和乘性关系对HRQOL的作用。考查了简单斜率以探查显著的交互作用。
结果: 样本人群中分别有77.4％和85.3％患有可能的PTSD和重性抑郁症, 73.0％有可能的
PTSD-抑郁共病。抑郁症状显著影响PTSD症状与总体心理HRQOL之间的关系 (β= 0.12,
p<0.001, ΔR2 = 0.014), 以及由情绪困扰导致的角色障碍 (β= 0.20, p <0.001, ΔR2 = 0.035)
。简单斜率分析显示, PTSD的影响在抑郁症状较轻者中更强, 在抑郁症状较严重者中更
弱。在校正模型中, 只有抑郁与所有心理和躯体HRQOL域均显著相关PTSD与躯体HRQOL,
角色情感障碍或生命力无关。
结论: 对于有严重抑郁症并发的患者, PTSD症状不再与心理HRQOL相关, 尤其是在情绪功能
相关领域。研究结果表明了在患有PTSD-抑郁共病的患者中以抑郁症为靶点的重要性。
1. Introduction
Major Depressive Disorder and posttraumatic stress dis-
order (PTSD) affect many military members and veterans,
with recent epidemiological data suggesting that approxi-
mately 21% and 14% of Canadian Armed Forces (CAF)
veterans endorse the presence of depression and PTSD,
respectively (Van Til, Sweet, & Poirier et al., 2017).
Previous work has shown that individuals with depression
or PTSD frequently report diminished life satisfaction and
difficulties within social and vocational domains
(Rapaport, Clary, Fayyad, & Endicott, 2005), consequences
that may persist even in the remission of psychiatric
symptoms (Angermeyer, Holzinger, Matschinger, &
Stengler-Wenzke, 2002). As such, comprehensive screen-
ing and treatment strategies should not only consider
patients’ symptomatology, but also their subjective func-
tioning across psychological, physical, and social domains,
broadly termed quality of life (QOL), or health-related
quality of life (HRQOL) for functioning specifically related
to health status (Mendlowicz & Stein, 2000). Although
depression and PTSD have independently been linked
with reductions in HRQOL (Hansson, 2002; Olatunji,
Cisler, & Tolin, 2007), there is scarce research on whether
the disorders interactively influence HRQOL. Considering
that depression and PTSD often co-occur (comorbidity
ranging between 36-70% within military samples)
(Campbell et al., 2007; Kehle et al., 2010; Zamorski et al.,
2016), it is imperative to develop a nuanced understanding
of the ways in which the two disorders may interact to
impact HRQOL.
Diminished QOL appears to be significantly associated
with depression (Goldney, Fisher, Wilson, & Cheok, 2000;
Hansson, 2002; Pyne et al., 1997) and PTSD (Hansson,
2002; Kehle et al., 2010; Mendlowicz & Stein, 2000;
Mogotsi, Kaminer, & Stein, 2000), with reductions that
are similar to or greater than for chronic physical condi-
tions (Alonso, Angermeyer, & Bernert et al., 2004; Hays,
Wells, & Sherbourne et al., 1995; Spitzer et al., 1995; Wells,
Stewart, & Hays et al., 1989). Using a well-validated mea-
sure of HRQOL, the SF-36 (Ware, Snow, & Kosinsk et al.,
1993), both depression and PTSD symptoms were
uniquely associated with all mental components (e.g. vital-
ity, social functioning) in samples of US and Canadian
veterans (Pittman, Goldsmith, Lemmer, Kilmer, & Baker,
2012; Richardson, Long, Pedlar, & Elhai, 2010, 2008). Of
note, neither disorder predicted physical HRQOL in US
veterans (Pittman et al., 2012), and only depression pre-
dicted physical HRQOL declines in Canadian veterans
(Richardson et al., 2010, 2008). Importantly, in both civi-
lian (Olatunji et al., 2007; Pagotto et al., 2015; Rapaport
et al., 2005; Schonfeld et al., 1997) and military (Kehle
et al., 2010; Olatunji et al., 2007) samples, depression and
PTSD symptoms have not only been shown to uniquely
predict QOL but have emerged as the strongest predictors
of QOL declines compared with other psychiatric symp-
toms and diagnoses. Although evidence suggests that
depression and PTSD contribute independently to
HRQOL reductions, it is unknown whether there are
any interaction effects in this relation.
The co-occurrence of depression and PTSD among
Canadian military members and veterans is high
(ranging from 41-62%) (Richardson et al., 2017;
Zamorski et al., 2016), the implications of which
may extend beyond the independent impact of either
disorder. Indeed, relative to those with depression or
PTSD alone, the presence of both disorders has been
linked with more severe psychiatric symptoms,
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greater suicidal ideation, and increased likelihood of
undesirable treatment outcomes (Blanchard, Buckley,
Hickling, & Taylor, 1998; Campbell et al., 2007;
Kramer, Booth, Han, & Williams, 2003, Steiner,
Boulos, & Mirocha et al., 2017). Further, compared
to those with only depression, those with comorbid
PTSD have exhibited significantly worse QOL
(Campbell et al., 2007; Steiner et al., 2017).
However, the impact of depression-PTSD comorbid-
ity on QOL is not entirely consistent within the
literature. In a study of US veterans, HRQOL impair-
ments were similar between those with depression
only, and those with comorbid depression and
PTSD. However, both depression groups tended to
report significantly more impairment on the SF-36
than those with PTSD only (Kramer et al., 2003). In
another study with currently serving US military
members, overall QOL and social functioning did
not differ between those with PTSD alone and those
with PTSD and comorbid conditions (including
depression) (Kehle et al., 2010). Variable findings
suggest there may be nuanced relations between
PTSD and depression with HRQOL that are masked
by generalized analyses; more precise analyses that
account for the interactions between depression and
PTSD symptoms may clarify such relations.
Classically, PTSD has been associated with military
populations, who may have had frequent exposure to
potentially traumatic events. As such, we intend to
examine the effect of PTSD on HRQOL, while con-
sidering the role of depression as an effect modifier.
To our knowledge, no study has examined whether
depression and PTSD symptoms interact to impact
HRQOL. Accordingly, the current study extends
research by assessing whether PTSD is differentially
associated with HRQOL across levels of depression
symptom severity. Using a treatment-seeking sample
of CAF members and veterans, we assessed the inde-
pendent and interactive contributions of PTSD and
depression on HRQOL after controlling for age, sub-
stance use disorder, and alcohol use disorder, each of
which has shown associations with QOL in prior
research (Richardson et al., 2008; Rudolf & Watts,
2002).
2. Methods
2.1. Participants and procedure
Participants included 545 treatment-seeking veterans
and currently serving CAF members, aged between 18
and 65 years old (see Table 1 for sample characteristics).
All participants were referred to a specialized clinic
(St. Joseph’s Health Care London, Operational Stress
Injury Clinic in London, Ontario, Canada) for outpa-
tient treatment of a service-related mental health con-
dition between January 2016 and April 2019. As part of
standard intake procedure, all participants completed
self-report questionnaires assessing demographic vari-
ables, psychological and physical symptoms, substance
and alcohol abuse, and HRQOL. All study participants
consented for their clinical data to be used for future
research, including the current study. This study was
approved by all relevant research boards and offices.
2.2. Clinical measures
2.2.1. Posttraumatic stress disorder
PTSD symptom severity was assessed using the PTSD
Checklist for the DSM-5 (PCL-5) (Blevins, Weathers,
Davis, Witte, & Domino, 2015). Participants reported
their past-month symptom severity, where higher
scores indicate greater PTSD symptom severity
(total score ranging from 0 to 80). Scores of 33 or
higher were considered indicative of probable PTSD.
(Bovin et al., 2016) The reliability and validity of the
PCL-5 have been well-established within treatment-
seeking military populations (current sample
α = 0.94) (Bovin et al., 2016; Wortmann et al., 2016).
2.2.2. Depression
Depression symptom severity was assessed using the
Patient Health Questionnaire-9 (PHQ-9) (Spitzer,
Kroenke, & Williams, 1999). Participants reported
their symptom severity within the past 14 days,
where higher scores indicated greater depressive
symptom severity (total score ranging from 0 to 27).
A score of 10 or higher was indicative of probable
major depression (Kroenke, Spitzer, & Williams,
2001). The PHQ-9 has exhibited reliability and valid-
ity across large clinical samples (current sample
α = 0.87) (Kroenke et al., 2001).
2.2.3. Alcohol misuse
Problematic drinking behaviours were assessed using
the Alcohol Use Disorders Identification Test
(AUDIT) (Saunders, Aasland, & Babor et al., 1993).
Participants reported their past-year drinking
Table 1. Sociodemographic characteristics of the study sam-
ple (sample size = 545).
Variable n or M % or SD
Sex
Male 463 85.0%
Female 82 15.0%
Education level
Less than high school 52 9.5%
Completed high school 145 26.6%
Some postsecondary 152 27.9%
Completed postsecondary 196 36.0%
Age at intake 44.6 11.3
Military status
Veteran 498 91.4%
Currently serving 47 8.6%
Marital status
Married or common-law 320 58.7%
Single, divorced, separated, or widowed 225 41.3%
Abbreviations. M, mean; SD, standard deviation.
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behaviours, where higher scores indicated more pro-
blematic alcohol use behaviour (total score ranging
from 0 to 41). Scores of 8 or greater signified prob-
able alcohol use disorder (Saunders, Aasland, &
Babor et al., 1993). Researchers have shown that the
AUDIT has adequate validity within clinical settings
(current sample α = 0.89) (Bohn, Babor, & Kranzler,
1995).
2.2.4. Substance abuse
Potentially problematic substance use was assessed
using the 10-item Drug Abuse Screening Test
(DAST-10) (Skinner, 1982). Participants reported
their past-year substance use, where higher scores
indicated more problematic substance use (total
score ranging from 0 to 10). Scores of three or higher
suggested probable substance use disorder (Yudko,
Lozhkina, & Fouts, 2007). Researchers have validated
the DAST-10 in inpatient populations (current sam-
ple α = 0.78) (Bohn, Babor, & Kranzler, 1991).
2.2.5. Health-related quality of life
HRQOL was measured using the 36-item Short-
Form Health Survey (SF-36) (Ware et al., 1993).
The SF-36 assessed mental and physical functional
impairment across eight domains which are used to
generate two summary scores, the Mental
Component Score (MCS) and the Physical
Component Score (PCS). Vitality (VT), Role
Emotional (RE; role limitations due to emotional
concerns), Social Functioning (SF), and Mental
Health (MH) subscales were used to inform MCS,
and Physical Functioning (PF), Role Physical (RP;
role limitations due to physical concerns), Bodily
Pain (BP), and General Health (GH) were used to
inform PCS. The mental health aggregate score and
subscales are of primary interest in light of reliable
support that PTSD and depression negatively impact
mental wellbeing and functioning. PTSD has gener-
ally not influenced the physical component and sub-
scale scores of HRQOL after controlling for
depression (Pagotto et al., 2015; Pittman et al.,
2012; Richardson et al., 2010, 2008), but we have
chosen to include all scales in analyses for compre-
hensiveness. Scores were calculated by summing
responses, transforming them to a 0–100 scale
(where higher scores indicated better functioning),
and standardizing them according to Canadian age-
and sex-based norms (Hopman, Towheed, &
Anastassiades et al., 2000). Component scores of
below 50 indicated below-average health (Ware
et al., 1993). The reliability and validity of the SF-
36 have been established within large samples across
several countries and clinical populations (current
sample α’s = 0.76-0.92 for subscales) (Gandek et al.,
1998; McHorney, Ware, Lu, & Sherbourne, 1994).
2.3. Data analysis
Hierarchical multiple linear regression was used to
assess whether PTSD and depression individually and
interactively predicted HRQOL. Separate analyses were
run to predict (1) MCS, and (2) PCS. In the case of
a significant interaction on either component score,
separate regressions were run to predict the component
subscale scores. Each regression model was adjusted for
age, substance use disorder, and alcohol use disorder.
Predictors were entered in five steps to assess their
incremental associations with HRQOL, Step 1: age,
Step 2: alcohol use disorder severity and substance
use disorder severity, Step 3: PTSD symptom severity,
Step 4: depression symptom severity, and Step 5:
a cross-product term between PTSD symptom severity
and depressive symptom severity to assess the interac-
tion between depression and PTSD. To probe signifi-
cant interactions, simple slopes were examined to
assess the relation between PTSD and HRQOL across
three levels of depression symptom severity (−1 SD, 0
SD, +1 SD). PTSD and depression were each mean-
centred prior to inclusion in regression models. To
protect against inflated rates of Type I error, we are
applying a Bonferroni correction based on the number
of separate regression models. Thus an alpha level of
0.05/6 = 0.008 was used for statistical significance in all
tests. Regression and correlations were conducted
using IBM SPSS Statistics, Version 25 and simple
slopes were examined using an SPSS Macro
(PROCESS) (Hayes, 2018).
2.4. Missing data
Consistent with SF-36 manual instructions (Ware
et al., 1993), missing data on the SF-36 were
imputed using participants’ personal means for the
relevant subscales, as long as participants had at
least 50% of the scores for that subscale. For all
other measures, missing data was handled using
multiple imputation, but was restricted to partici-
pants that had 20% or less missing data on any of
the relevant scales. We inspected the pattern of
missing data from the DAST-10, AUDIT, PCL-5,
and PHQ-9, and determined that the data appeared
to be missing at random. We then used multiple
imputation by chained equations (MICE) in
R (Buuren & Groothuis-Oudshoorn, 2010) to
impute the data missing from these fields.
Predictive mean matching was used for all values,
and a max iteration value of 50 was set for the
equation with the random seed set to 42. Auxiliary
variables used for MICE included demographic vari-
ables (e.g. marital status, age, education) and psy-
chiatric symptoms assessed at clinic intake (e.g.
general anxiety disorder symptoms, somatization);
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SF-36 scores were also included as auxiliary vari-
ables, but these values were not imputed.
3. Results
3.1. Participant characteristics
Of 719 eligible participants, 29 were excluded for miss-
ing demographic information, and 145 were excluded
for either missing more than 20% of item scores on the
AUDIT, DAST-10, PCL-5, or PHQ-9, or more than
50% of scores on any one of the SF-36 mental health
subscales (final N = 545). Excluded participants were
compared to those with complete data using t-tests for
continuous variables (age, alcohol use disorder, sub-
stance use disorder, PTSD, depression, and SF-36
scores), and using chi-square tests for categorical
demographic variables (marital status, education, and
military status). The samples were comparable on all
variables, except for marital status; participants with
complete data were more likely to be married
(χ2 = 5.11, p = 0.02). Demographic characteristics are
presented in Table 1.
More than a third of participants met the probable
alcohol use disorder cut-off (n = 203; 37.2%), and
relatively fewer participants met the cut-off criteria for
probable substance use disorder (n = 77; 14.1%). Most
participants had probable PTSD (n = 422; 77.4%), and
probable major depression (n = 465; 85.3%). Most of
the participants with probable depression also had
probable PTSD (n = 398; 85.6%). Considering that
scores under 50 indicate below-average health, partici-
pants had considerably compromised HRQOL accord-
ing to the MCS and PCS (see Table 2).
3.2. Hierarchical regression models
3.2.1. MCS and MCS subscales
Table 3 depicts each of the hierarchical models pre-
dicting MCS. More severe substance abuse was asso-
ciated with lower MCS, indicating worse mental
HRQOL. However, once PTSD symptom severity
was added to the model in Step 3, only PTSD sig-
nificantly predicted of MCS (ΔR2 = 0.26). In Step 4,
depression and PTSD symptom severity were the
only significant predictors of MCS (ΔR2 = 0.13). For
both disorders, as symptom severity increased, MCS
decreased. In the final model, depression and PTSD
symptom severity remained significant independent
predictors of MCS, and the interaction between
depression and PTSD was also significant (Adj.
R2 = 0.43, ΔR2 = 0.01).
To probe the interaction on MCS, the simple slopes
of PTSD symptom severity on MCS were analysed at
−1 SD, 0 SD, and +1 SD of depression symptoms (see
Figure 1(a)). At −1 SD and 0 SD, elevated PTSD
symptom severity was significantly associated with
reduced MCS (b = −0.19, t(538) = −5.08, p < 0.001
and b = −0.11, t(538) = −3.42, p < 0.001, respectively).
At +1 SD, greater PTSD symptom severity no longer
predicted declines in MCS (b = −0.04, t(538) = −0.86,
p = 0.39). Thus, the impact of PTSD symptom severity
on MCS decreased as depression symptoms increased,
Table 2. Clinical and health-related quality of life character-
istics of the study sample.
Variable M (SD)
Alcohol use severity (AUDIT) 7.7 (7.9)
Substance use severity (DAST-10) 1.2 (1.8)
PTSD severity (PCL-5) 46.3 (18.0)
Depression severity (PHQ-9) 16.7 (6.2)
MCS (SF-36) 20.7 (12.9)
Vitality 24.0 (10.7)
Social functioning 18.5 (12.4)
Role emotional 24.2 (11.1)
Mental health 22.5 (13.4)
PCS (SF-36) 32.4 (13.6)
Physical functioning 27.9 (16.2)
Role physical 29.2 (13.4)
Bodily pain 32.1 (10.4)
General health 26.9 (11.3)
Abbreviations. AUDIT, Alcohol Use Disorders Identification Test; DAST,
Drug Abuse Screening Test; M, mean; MCS, Mental Component Score;
PCL-5, Post-traumatic Stress Disorder; Checklist for DSM-5; PCS,
Physical Component Score PHQ-9, Patient Health Questionnaire; SD,
standard deviation; SF-36, 36-Item Short Form Survey.
Table 3. Hierarchical regression: Depression x PTSD symptomatology predicting Mental Component Score (MCS).
Steps 1&2 Step 3 Step 4 Step 5
Variable b(SE) β b(SE) β b(SE) β b(SE) β
Zero-order
Correlationb
Age −0.11(0.05) −0.10 −0.10(0.04) −0.09 −0.07(0.04) −0.07 −0.07(0.04) −0.06 −0.07
Substance use
severity
−0.89(0.32)** −0.16 −0.34(0.28) −0.08 −0.13(0.27) −0.04 −0.17(0.25) −0.04 −0.10
Alcohol use
severity
−0.11(0.07) −0.05 −0.00(0.06) 0.01 −0.01(0.06) 0.00 −0.01(0.06) 0.00 −0.13**
PTSD severity −0.38(0.03)*** −0.52 −0.13(0.03)*** −0.18 −0.11(0.03)*** −0.16 −0.53***
Depression
severity
−1.05(0.10)*** −0.50 −1.00(0.10)*** −0.48 −0.63***
PTSD x Depression 0.01(0.00)*** 0.12
Adjusted R2 0.024a 0.287 0.414 0.426
ΔR2 0.026a*** 0.262*** 0.127*** 0.014***
**p <0.008; ***p <0.001.
aEstimate is for Step 2 (Step 1 Adjusted R2 =0.002).
bZero-order correlation with mental component score (Pearson r or Spearman ρ, depending on normality parameters)
Abbreviations. b, unstandardized coefficient; β, standardized beta coefficient; SE = standard error for b; PTSD, posttraumatic stress disorder.
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with no significant impact of PTSD on MCS for those
with more severe depression.
The same 5-step hierarchical regression analyses
were applied to each MCS subscale. In Step 4, with all
individual predictors entered, depression symptom
severity was the only significant predictor for VT
(b = −1.08, p < 0.001), and RE (b = −0.61, p < 0.001).
For each outcome, as depression symptoms increased,
the HRQOL domain scores decreased. For SF and MH,
both PTSD symptom severity (b = −0.19, p < 0.001;
b = −0.18, p < 0.001), and depression symptom severity
(b = −0.88, p < 0.001; b = −1.23, p < 0.001) were
significant predictors. For each outcome, as PTSD and
depression symptoms increased, subscale scores
decreased. In the final models, the interaction terms
were significant for RE (b = 0.02, p < 0.001, Adj.
R2 = 0.22, ΔR2 = 0.04) but not for SF, MH, and VT.
The relation between PTSD and RE was analysed at
three levels of depression symptoms (see Figure 1(b)).
Greater PTSD symptom severity predicted decreased
RE scores at −1 SD (b = −0.15, t(538) = −3.98,
p < 0.001), but not at 0 SD (b = −0.04, t(538) = −1.30,
p = 0.19), or at +1 SD (b = 0.07, t(538) = 1.54, p = 0.12).
Thus, PTSD symptom severity was only negatively
associated with RE for those with relatively low levels
of depression. As depression symptoms increased,
PTSD symptom severity no longer impacted RE.
3.2.2. PCS
Following the same hierarchical steps to predict PCS,
no covariates showed significant associations. When
PTSD was added to the model in Step 3, elevated
symptoms were associated with lower PCS, indicating
worse HRQOL (ΔR2 = 0.05). However, depression
symptomatology was the only significant predictor
when added in Step 4 (ΔR2 = 0.02). PCS decreased
as depression symptoms increased. Depression
remained the only significant predictor in the final
model, where neither PTSD nor the interaction were
significant (ΔR2 < 0.001; See Table 4).
4. Discussion
Our research presents novel findings regarding the
interactive impact of depression and PTSD symptoms
on HRQOL. After adjusting for age, and alcohol and
substance disorder symptoms, depression severity
significantly moderated the association between
PTSD symptoms and the mental component of
HRQOL; this moderation effect was not present for
physical HRQOL. Depression and PTSD symptoms
were each uniquely associated with reduced mental
HRQOL. In contrast, only symptoms of depression
were associated with reduced physical HRQOL.
Consistent with prior research (Richardson et al.,
Table 4. Hierarchical regression: Depression x PTSD symptomatology predicting Physical Component Score (PCS).
Variable
Steps 1&2 Step 3 Step 4 Step 5 Zero-order
Correlationbb(SE) β b(SE) β b(SE) β b(SE) β
Age −0.03(0.05) −0.02 −0.02(0.05) −0.02 −0.01(0.05) −0.01 −0.01(0.05) −0.01 −0.03
Substance use
severity
0.20(0.34) 0.03 0.45(0.34) 0.06 0.54(0.33) 0.07 0.55(0.34) 0.07 0.03
Alcohol use
severity
−0.01(0.08) −0.00 0.05(0.08) 0.03 0.04(0.08) 0.03 0.05(0.08) 0.03 0.01
PTSD severity −0.17(0.03)*** −0.23 −0.06(0.05) −0.08 −0.07(0.05) −0.09 −0.21***
Depression
severity
−0.47(0.13)*** −0.21 −0.49(0.13)*** −0.22 −0.25***
PTSD x Depression −0.00(0.01) 0.04
Adjusted R2 −0.004a 0.044 0.066 0.065
Δ R2 0.001a 0.050*** 0.023*** 0.001
***p <0.001.
aEstimate is for Step 2 (Step 1 Adjusted R2 = −0.001).
bZero-order correlation with physical component score (Pearson r or Spearman ρ, depending on normality parameters)
Abbreviations. b, unstandardized coefficient; β, standardized beta coefficient; SE = standard error for b; PTSD, posttraumatic stress disorder.
Figure 1. Predicted Mental Component Score (MCS), and Role Emotional (RE) according to posttraumatic stress disorder (PTSD)
symptom severity, across three levels of depression symptom severity. Higher scores on PTSD and depression indicate more
severe symptomatology. Higher scores on MCS and RE indicate better health-related quality of life.
**p <0.01. ***p <0.001.
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2017; Seal et al., 2009; Zamorski et al., 2016), a large
portion of our sample reported comorbid PTSD and
depression, attesting to the importance of examining
their interactive and relative relations with HRQOL.
Current findings add to the mounting evidence
that depression and PTSD are uniquely associated
with mental HRQOL (Rapaport et al., 2005;
Schonfeld et al., 1997). Of note, however, whereas
PTSD symptom severity was an independent predic-
tor for MCS, MH, and SF, depression symptoms were
independently associated with reduced functioning
on all mental subscales. The consistent negative
impact of depression across all mental HRQOL
domains has been reliably reported (Goldney et al.,
2000; Hays et al., 1995; Richardson et al., 2010, 2008;
Schonfeld et al., 1997), and our findings reinforce the
claim that depression may exert the most wide-
spread and strongest negative impact on HRQOL
compared to anxiety or trauma-related disorders
(Ikin, Creamer, Sim, & McKenzie, 2010; Olfson
et al., 1997; Pittman et al., 2012). Although PTSD
has been linked with reductions across all mental
components of HRQOL in prior research (Pittman
et al., 2012; Richardson et al., 2010, 2008), this find-
ing has been inconsistent as others have reported that
PTSD predicted only a subset of mental HRQOL
domains after adjusting for comorbidities (e.g.
depression and alcohol use) (Kehle et al., 2010;
Pagotto et al., 2015). Notably, out of the subsample
with probable depression, 86% also had probable
PTSD; the proportion of those with probable PTSD
who also had depression was even greater (94%). The
direct and moderated impact of depression on
HRQOL further highlights the need to assess, moni-
tor, and target depressive symptoms in treatment-
seeking veterans with PTSD.
In our sample, we found that higher PTSD symp-
toms were associated with reductions in mental
HRQOL and role emotional functioning across low
levels of depression, but not for those with moderate
(for role emotional) or high depressive symptoms. In
individuals with high depressive symptoms, HRQOL
remained steadily low regardless of PTSD symptom
severity. This interaction may explain the inconsis-
tent findings in previous research. After controlling
for depressive and other psychiatric symptoms, there
is evidence that PTSD is associated HRQOL
(Richardson et al., 2008), and evidence that it does
not affect functional impairment (Olfson et al., 1997).
Similarly, compared to those with depression only,
research has found both that PTSD comorbidity pre-
dicts further declines in quality of life (Steiner et al.,
2017), and that it does not (Kramer et al., 2003).
Among a number of possible explanations, the lack
of an association between PTSD symptom severity
and HRQOL in the most severely depressed partici-
pants could represent a floor effect. That is, the
HRQOL scores within the high depression severity
participants may be so low, and thus exhibit such
little variation, that meaningful differences due to
PTSD symptoms are undetectable. This could be
due to a real inability to experience further declines
in HRQOL, or it could represent a lack of sensitivity
of the HRQOL measure among those with consider-
ably compromised wellbeing. Though, it is worth
noting that the interaction explains only a small
amount of HRQOL variance, with the main effects
of depression and PTSD symptoms representing
moderate to large effect sizes (Cohen, 1992). Thus
the importance of each disorder in reducing
HRQOL should not be overlooked. Notably, due to
the treatment-seeking nature of our sample, many
study participants had substantial illness burden and
severity; even at 1 SD below the mean depression
symptom severity score, participants were above the
cut-off for probable depression. Importantly, the
interaction evidenced that depression was the most
consistently and critically related to mental and emo-
tional aspects of HRQOL (Ikin et al., 2010; Olfson
et al., 1997; Pittman et al., 2012; Schonfeld et al.,
1997).
Only depression was significantly associated with
physical HRQOL in the fully adjusted regression
model. Our findings thus emphasize the wide-
ranging negative impact of depression on HRQOL
domains, whether mental or physical. Similarly,
researchers have revealed that depression, but not
PTSD, has been independently associated with phy-
sical HRQOL domains (Pagotto et al., 2015; Pittman
et al., 2012; Richardson et al., 2010, 2008). Depression
has been reliably associated with negative physical
health outcomes, including stroke (Pan, Sun,
Okereke, Rexrode, & Hu, 2011), diabetes
(Vancampfort et al., 2016), hypertension (Patten
et al., 2009), obesity (Strine et al., 2008), and cardio-
vascular disease (Musselman, Evans, & Nemeroff,
1998). Although an extensive review of the reasons
underlying such associations is beyond the scope of
this paper, correlates of depression including neu-
roendocrine alterations (e.g. hyperactive sympathetic
nervous system) (Musselman et al., 1998), inflamma-
tion and immune system dysfunction (Leonard, 2010;
Shimbo, Chaplin, Crossman, Haas, & Davidson,
2005), and increased unhealthy behaviours (e.g.
smoking, physical inactivity, heavy drinking) (Strine
et al., 2008) may mediate changes in physical health
and functioning. It is possible that PTSD does not
account for changes in physical HRQOL beyond
these correlates, and indeed PTSD is less consistently
associated with physical HRQOL in the literature.
A recent meta-analysis noted considerable heteroge-
neity in PTSD and physical functioning relations, but
did find a small and significant effect of PTSD on
physical HRQOL (Pacella, Hruska, & Delahanty,
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2013). The nonsignificant relation in the current
study may be influenced by our measure, as larger
effect sizes have been found for general health symp-
toms and health conditions, relative to HRQOL
(Pacella et al., 2013). Additionally, larger effect sizes
between PTSD and physical health outcomes have
been found in female samples, and so our mostly
male sample may have influenced our results
(Pacella et al., 2013). Generally, both depression and
PTSD evidenced smaller slopes for physical changes
than for changes in mental HRQOL, which may
explain the lack of interaction. We hypothesized
that a floor effect on mental functioning occurred
due to such severely impacted scores in those with
high depressive symptoms. Such a floor effect is less
likely if the influence of depression is smaller. The
complex relations between mental illnesses and phy-
sical health are worth further exploration in future
research.
Our study had limitations worth noting. Data was
collected at clinical intake and the analysis was lim-
ited to a cross-sectional assessment; accordingly,
causality cannot be determined. Because all partici-
pants were treatment-seeking, the majority of the
study sample had severe, chronic mental illnesses,
with particularly high rates of depression and PTSD
comorbidity. As such, our findings may not general-
ize to those without comorbidities, those with sub-
clinical levels of depressive or PTSD symptoms, or
non-military populations. Treatment-seeking in itself
may also be uniquely related to quality of life. For
instance, those seeking treatment may have improved
quality of life compared to those with similar symp-
tom severity of either PTSD or depression by way of
their access to devoted clinicians with means to pro-
vide therapeutic support. Of notable significance,
although we explored the impact of PTSD symptoms
at three levels of depression severity, the subsample
with high levels of depression severity and low levels
of PTSD severity (i.e. −1 SD) was small; thus, analyses
may have been underpowered to identify the associa-
tion of those with relatively ‘low’ PTSD symptoma-
tology among severely depressed individuals. Future
research should address these limitations to confirm
and further validate our findings across different
populations and symptom profiles. Nonetheless, our
study had several strengths, including systematic and
standardized assessments, optimal missing data hand-
ling, and access to a large treatment-seeking military
sample, which can be challenging to acquire for
research purposes, particularly within Canada.
5. Conclusion
The present study demonstrated that depression
severity moderates the relation between PTSD and
HRQOL. Although extant research has highlighted
the significant and unique impact of both PTSD and
depression on HRQOL, due to their high levels of
comorbidity, it was imperative to explore whether
PTSD and HRQOL were differentially associated
across varying severity of depression symptoms. We
found that depression and PTSD each explained
unique variation in the aggregate mental HRQOL,
as well as social functioning, mental health, and bod-
ily pain. However, only depression significantly pre-
dicted both the component scores and all mental
HRQOL domains. Importantly, we showed that
PTSD was associated with HRQOL among the mod-
erately and mildly depressed, but not among the
severely depressed participants. This trend held for
general mental HRQOL, as well as emotion-related
role limitations. The detrimental impact of depres-
sion on HRQOL is thus at the forefront of our find-
ings and speaks to the importance of targeting
depression symptomatology among treatment-
seeking veterans with comorbidities.
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